Showing results 55 to 74 of 101
< previous
next >
| Issue Date | Title | Author(s) |
| 2018-07-01 | In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry | Watanabe, S; Kuzhiumparambil, U; Fu, S |
| 2022-05 | Intelligence benefit of the 3-methoxytyramine to tyramine ratio in equine urine. | Elbourne, M; Cawley, A; Stanley, S; Bowen, C; Fu, S |
| 2021-03 | Liquid chromatography-high-resolution mass spectrometry analysis of erectile dysfunction drugs and their analogues in food products | Yusop, AYM; Xiao, L; Fu, S |
| 2022-02-01 | Liquid Chromatography-triple Quadrupole Mass Spectrometry Simultaneously Detecting Paraquat and Metabolites in Biological Samples | Meng, Y; Gong, D; Li, W; Wen, Y; Fan, Z; Zhang, C; Wang, T; Fu, S; Wei, Z; Yun, K |
| 2022-05 | Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry. | Tou, K; Cawley, A; Bowen, C; Sornalingam, K; Fu, S |
| 2017 | The mechanical properties of plastic evidence bags used for collection and storage of drug chemicals relevant to clandestine laboratory investigations. | Michelot, H; Stuart, B; Fu, S; Shimmon, R; Raymond, T; Crandell, T; Roux, C |
| 2017-07-01 | Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Nguyen, MA; Cameron, J; Fu, S |
| 2022-09 | Metabolomic analysis of equine urine to determine route of altrenogest administration | Elbourne, M; Fu, S; Cawley, A; Bowen, C; Gupta, A |
| 2022-05 | Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues. | Keen, B; Cawley, A; Reedy, B; Fu, S |
| 2021-01-01 | Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples | Leong, HS; Watanabe, S; Kuzhiumparambil, U; Fong, CY; Moy, HY; Yao, YJ; Witting, PK; Fu, S |
| 2020 | Monodisperse silica nanoparticle suspension for developing latent blood fingermarks | Meng, L; Ren, Y; Zhou, Z; Li, C; Wang, C; Fu, S |
| - | NBOMe Test | Fu, S; Clancy, L; Shimmon, RS |
| 2023-01-01 | New Psychoactive Substances | Alonzo, M; Fu, S; Houck, MM |
| 2008-01-01 | Novel automated extraction method for quantitative analysis of urinary 11-nor-Δ<sup>9</sup>-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) | Fu, S; Lewis, J |
| 2010-01-01 | A novel reductive transformation of oxazepam to nordiazepam observed during enzymatic hydrolysis | Fu, S; Lewis, J; Wang, H; Keegan, J; Dawson, M |
| 2011-01 | Oxidation of MDMA in urine after exposure to bleach | Pham, AQ; Fu, S; Dawson, M; Gerostamoulos, D; Beyer, J |
| 2015-03-01 | Oxidation of testosterone by permanganate and its implication in sports drug testing | Kuzhiumparambil, U; Watanabe, S; Fu, S |
| 2013-04-01 | Pethidinic acid: Corroboration of a doctors denial of pethidine re-use | Lewis, J; Shimmon, R; Fu, S |
| 2022-11 | Portable testing techniques for the analysis of drug materials | Alonzo, M; Alder, R; Clancy, L; Fu, S |
| 2017-06 | The postmortem distribution of bromadiolone and its metabolite-benzylideneacetone in poisoned dogs | Zhao, D; Yang, Z; Wei, Z; Fu, S; Liu, L; Yun, K |
